Burlingame, CA
News Category

Oncotelic's PDAOAI Platform and HCC Research Signal New Direction for AI-Driven Drug Discovery
Oncotelic Therapeutics unveiled its PDAOAI discovery platform and a four-gene HCC signature at Drug Discovery 2026, highlighting how AI-powered litera...
October 15, 2026Read the full article →

Oncotelic Opens BIO REBOOT Registration, Unveils PDAOAI Presentations at Drug Discovery 2026
Oncotelic Therapeutics invites scientists and AI developers to join its PDAOAI-powered BIO REBOOT initiative and announces two keynote presentations a...
October 5, 2026Read the full article →


